About this trial
This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults 18 years or older
African American and/or Latinx
Uncontrolled stage 2 hypertension, BP >/= 140/90
Patient is following with Rush primary care provider in eligible Rush primary care clinics
Disqualifiers
Organ transplant recipient
On dialysis
Patient is already participating in another remote hypertension monitoring program
Patient is not interested in participating in the program
Trial design
Parallel
Treatments tested in this trial
E3 Multidisciplinary Team
BehavioralThe E3 Multidisciplinary team is composed of a remote pharmacist, social worker, and nurse working together with patients via a remote monitoring, educational hypertension phone app to overcome barriers to hypertension control via behavioral change, medication adherence and titration, diet and lifestyle education and resource referrals for social needs.
E3 Self-Guided Hypertension Education Program
BehavioralPatients will receive timed, mailed educational materials on hypertension self-monitoring, diet and lifestyle modifications to supplement usual clinic-based hypertension care with their primary care doctor. A research assistant will ensure patients have home blood pressure monitors on enrollment, and will remind patients to check their blood pressures and follow-up with their primary care doctors at 3 months and 6 months.
Treatment groups
Trial outcomes
Primary outcomes
Systolic blood pressure change at 6 months
Percentage of participants with a decrease in systolic blood pressure of at least 10mmHg between pre and post clinic-based blood pressure measurements.
Secondary outcomes
Hypertension control at 9 months
Percentage of participants with hypertension control (BP\< 140/90) at 9 months
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rush University Medical Center
Lead sponsor
Novartis Pharmaceuticals
Collaborator